• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Balaxi Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 22472.0
  • ISIN : INE618N01022
63.92 -1 (-1.30%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    62.31

  • Today’s High

    65.90

  • Open

    65.00

  • Perv Close

    64.76

  • 52W Low

    50.42

  • 52W High

    151.45

Key Indicators

  • P/E(TTM)

    84.11

  • Mar.Cap (₹Cr.)

    352.89

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.06

  • Debt-Equity Ratio

    -1.30

  • AGM Date

    28-Mar-2025

  • EPS

    0.76

  • P/E Ratio

    84.11

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    352.89

  • RONW (%)

    -25.94

  • ROCE (%)

    20.69

Score Board

  • Equity (₹ in Cr.)

    11.04

  • BV (₹)

    23.10

  • Sales( ₹ in Cr.)

    70.20

  • NP (in Cr.)

    3.69

  • NP Var(%)

    -77.0

  • Div%

    0.0

  • CPS (₹)

    0.80

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    352.89

  • 52 Week High

    151.45

  • 52 Week Low

    50.42

  • Price BSE

    0.0

  • Price NSE

    64.00

  • Market Capital( in Cr.)

    352.89

  • P/C Ratio

    84.10

  • P/E Ratio

    95.70

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 70.20 108.14 101.29 86.87 45.63 13.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 13.60
Net Sales 70.20 108.14 101.29 86.87 45.63 13.60
Other Income 2.40 6.60 2.75 1.81 0.59 0.89
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 72.59 114.74 104.04 88.68 46.23 14.48
EXPENDITURE :
Raw Materials 0.00 0.00 0.00 0.00 0.00 13.60
Power & Fuel Cost 0.00 0.00 0.00 0.00 0.00 13.60
Employee Cost 5.04 4.04 2.90 1.95 1.75 0.90
Other Manufacturing Expenses 0.60 0.38 0.26 0.53 0.74 0.25
Selling & Administrative Expenses 2.79 4.76 3.93 2.18 1.71 0.59
Miscellaneous Expenses 0.60 0.38 0.26 0.53 0.74 0.25
Less : Pre-operative Expenses Capitalised :
Total Expenditure 67.01 92.29 84.34 68.08 37.04 12.04
Operating Profit 0.04 0.04 0.02 0.00 0.00 0.07
Interest 1.54 0.46 0.06 0.01 0.00 0.00
Gross Profit 5.58 22.45 19.70 20.60 9.19 2.44
Depreciation 0.51 0.52 0.25 0.09 0.01 0.00
Profit Before Tax 5.58 22.45 19.70 20.60 9.19 2.44
Tax 2.04 5.17 5.00 5.46 2.69 0.47
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.11 1.06 0.03 0.00 0.00 0.00
Reported Net Profit 3.65 16.22 14.67 15.13 6.50 1.97
Extraordinary Items 5.58 22.45 19.70 20.60 9.19 2.44
Adjusted Net Profit 3.65 16.22 14.67 15.13 6.50 1.97
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.50 0.00 0.00 0.00
P & L Balance carried down 3.65 16.22 14.67 15.13 6.50 1.97
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 5.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.50 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.55 16.17 14.67 15.13 8.65 6.47
Book Value 0.00 0.00 0.50 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.50 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    65.99%

  • Public Share Holding

    34.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 35,000,000 63.40 35,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,431,770 2.59 1,431,770 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 36,431,770 65.99 36,431,770 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 13,160 0.02 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,098,745 16.48 9,098,745 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,111,905 16.50 9,098,745 3
2] Non Institution
Bodies Corporate 1,762,511 3.19 1,762,511 50
Clearing Members 50 0.00 50 1
Directors of their Relatives 50,000 0.09 50,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 199,740 0.36 199,740 95
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,133,307 2.05 1,133,307 115
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,667,631 3.02 1,667,631 5
Individuals holding nominal share capital up to Rs. 1 lakh 3,683,830 6.67 3,543,790 8,254
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,166,756 2.11 1,166,756 2
Sub Total 9,663,825 17.50 9,523,785 8,523
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 55,207,500 100.00 55,054,300 8,529

Company Background

Balaxi Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Balaxi Pharmaceuticals Ltd
  • BSE Code : 22472.0
  • ISIN : INE618N01022

  • Incorporation Year

    1942

  • Registered Office

    41/298-D2 2nd Flr Saniya Plaza
    Mahakavi Bharatiyar Road, Cochin,
    Kerala-682035

  • Telephone

    91-484-4032952/6596725

  • FAX

  • Chairman

  • Managing Director

    Ashish Maheshwari

  • Company Secretary

    Mohith Kumar Khandelwal

  • Auditor

    P Murali & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    SKDC Consultants Ltd
    Surya 35 Mayflower ,
    Avenue Sowripalayam ,Road
    Mumbai - Coimbatore - 641 028

Balaxi Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Balaxi Pharma 63.92 72.59 70.20 84.11 5.99
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92